Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/208.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Virus or component thereof > Retroviridae (e.g., feline leukemia virus, bovine leukemia virus, avian leukosis virus, equine infectious anemia virus, rous sarcoma virus, htlv-i, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the retrovirus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.










Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Patent Number Title Of Patent Date Issued
8703142 Methods to bypass CD4+ cells in the induction of an immune response Apr. 22, 2014
8673311 Bacterial spore having therapeutic agent adsorbed on its surface Mar. 18, 2014
8673612 Synthetic viruses and uses thereof Mar. 18, 2014
8637036 Neutralizing antibodies to HIV-1 and their use Jan. 28, 2014
8637044 Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and Jan. 28, 2014
8628782 Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction Jan. 14, 2014
8623382 Immunogenic compositions for inducing an immune response to HIV Jan. 7, 2014
8623379 Compositions and methods for generating an immune response Jan. 7, 2014
8609109 HIV vaccine formulations Dec. 17, 2013
8603490 Modified human immunodeficiency virus clade C envelope polypeptides obtained from a zambian isolate Dec. 10, 2013
8586056 HIV-1 envelope glycoprotein Nov. 19, 2013
8586052 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Nov. 19, 2013
8586055 DNA immunization protocols Nov. 19, 2013
8580492 Screening method for the identification of inhibitors of HIV Tat methylation by the lysine methyltransferase Set7/9 Nov. 12, 2013
8574590 Lipoparticles comprising proteins, methods of making, and using the same Nov. 5, 2013
8568734 Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope Oct. 29, 2013
8563693 Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III Oct. 22, 2013
8557533 Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 Oct. 15, 2013
8551483 Methods of treating viral infections by administering KIR2DL-binding antibodies Oct. 8, 2013
8551497 Microbial vaccine and vaccine vector Oct. 8, 2013
8535684 Methods of inhibiting HIV infectivity Sep. 17, 2013
8501193 Stabilized Tat antigen and the use thereof for anti-HIV vaccination Aug. 6, 2013
8486420 Live virus vaccines Jul. 16, 2013
8475799 HIV-1 GP41 neutralization domain and use thereof Jul. 2, 2013
8470334 Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics Jun. 25, 2013
8470527 Method of inhibiting HIV-1 replication by administering modified GP41 C34 peptide derivatives with enhanced pharmacological properties Jun. 25, 2013
8460678 Use of triplex structure DNA in transferring nucleotide sequences Jun. 11, 2013
8454972 Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen Jun. 4, 2013
8450056 Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses May. 28, 2013
8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) May. 7, 2013
8420104 Lentiviral gene transfer vectors and their medicinal applications Apr. 16, 2013
8414900 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Apr. 9, 2013
8394581 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test Mar. 12, 2013
8389275 Fusion proteins of HIV regulatory/accessory proteins Mar. 5, 2013
8367315 Inactivation of reverse transcriptases by azido-diarylpyrimidines Feb. 5, 2013
8367061 Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs) Feb. 5, 2013
8367068 Use of triplex structure DNA in transferring nucleotide sequences Feb. 5, 2013
8338089 Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity Dec. 25, 2012
8338582 Anti-HIV immunogens and methods for inducing an immune response Dec. 25, 2012
8333980 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein Dec. 18, 2012
8323661 Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Dec. 4, 2012
8323662 Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein Dec. 4, 2012
8318419 Antiviral screening method to identify inhibitors of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P.sub.2] binding to the HIV gag matrix (MA) protein Nov. 27, 2012
8309098 Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs) Nov. 13, 2012
8293465 Method for the detection of human immunodeficiency virus envelope (HIV) glycoprotein utilizing carbohydrate binding module (CBM) 20 or 21 Oct. 23, 2012
8268323 Conformationally stabilized HIV envelope immunogens Sep. 18, 2012
8236324 Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens Aug. 7, 2012
8226955 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes Jul. 24, 2012
8206720 Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopes Jun. 26, 2012
8198088 Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more Jun. 12, 2012

1 2 3 4 5 6 7 8 9 10 11 12 13 14










 
 
  Recently Added Patents
System and method for locating, tracking, and/or monitoring the status of personnel and/or assets both indoors and outdoors
Lock monitoring
Candle holder
Cooler
Fabrication method of semiconductor device and fabrication method of dynamic threshold transistor
Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
Two dimensional magnetic sensor immune to skew angle misalignment
  Randomly Featured Patents
Method of deicing commercial, military and private aircraft
Telephone base
Shear clamping method
Creation and use of a moving reference frame for NMR imaging of flow
Orthopaedic instrumentation assembly having an offset bushing
Method and system to manufacture stacked chip devices
Two-piece fitted linen for a labor and delivery mattress
Method of manufacturing an integral asymmetrical membrane
Irradiation device and method for the treatment of acne and acne scars
Carriage assembly for an elevating scraper dump linkage and method of installing